Skip to main content
PMC home page
PPAR Research logoLink to PPAR Research
. 2019 Jul 21;2019:4309068. doi: 10.1155/2019/4309068

Corrigendum to “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors”

Elisabetta Benedetti 1, Renato Galzio 2, Barbara D'Angelo 1, Maria Paola Cerù 1, Annamaria Cimini 1,✉
PMCID: PMC6679841  PMID: 31428141

The article titled “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors” [1] was found to contain material in Sections 1, 2, and 3 from published work and to have missing attributions and errors in citations. The articles are as follows:

  1. M. T. Heneka and G. E. Landreth, “PPARs in the brain,” Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 1031–1045, 2007. https://doi.org/10.1016%2fj.bbalip.2007.04.016. [2] (Cited as reference [36]).

  2. Lars Tatenhorst, Eric Hahnen, and Michael T. Heneka, “Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors,” PPAR Research, vol. 2008, Article ID 204514, 9 pages, 2008. https://doi.org/10.1155/2008/204514. [3] (not cited).

  3. Markus P. Kummer and Michael T. Heneka, “PPARs in Alzheimer's Disease,” PPAR Research, vol. 2008, Article ID 403896, 8 pages, 2008. https://doi.org/10.1155/2008/403896. [4] (not cited).

  4. J. N. Feige, L. Gelman, L. Michalik, B. Desvergne, and W. Wahli, “From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions,” Progress in Lipid Research, vol. 45, no. 2, pp. 120–159, 2006. https://doi.org/10.1016%2fj.plipres.2005.12.002. [5] (cited as reference [30]).

  5. A. Cimini, E. Benedetti, L. Cristiano et al., “Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons,” Neuroscience, vol. 130, no. 2, pp. 325–337, 2005. https://doi.org/10.1016%2fj.neuroscience.2004.09.043. [6] (cited as reference [81]).

References

  • 1.Benedetti E., Galzio R., D'Angelo B., Cer M. P., Cimini A. PPARs in human neuroepithelial tumors: PPAR ligands as anticancer therapies for the most common human neuroepithelial tumors. PPAR Research. 2010;2010:9. doi: 10.1155/2010/427401.427401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Heneka M. T., Landreth G. E. PPARs in the brain. Biochimica et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids. 2007;1771(8):1031–1045. doi: 10.1016/j.bbalip.2007.04.016. [DOI] [PubMed] [Google Scholar]
  • 3.Tatenhorst L., Hahnen E., Heneka M. T. Peroxisome proliferator-activated receptors (PPARs) as potential inducers of antineoplastic effects in CNS tumors. PPAR Research. 2008;2008:9. doi: 10.1155/2008/204514.204514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kummer M. P., Heneka M. T. PPARs in alzheimer's disease. PPAR Research. 2008;2008:8. doi: 10.1155/2008/403896.403896 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research. 2006;45(2):120–159. doi: 10.1016/j.plipres.2005.12.002. [DOI] [PubMed] [Google Scholar]
  • 6.Cimini A., Benedetti E., Cristiano L., et al. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience. 2005;130(2):325–337. doi: 10.1016/j.neuroscience.2004.09.043. [DOI] [PubMed] [Google Scholar]

Articles from PPAR Research are provided here courtesy of Wiley

RESOURCES